Remember too we have the United European Gastroenterology Week coming up next month, where Immuron will present the final preclinical colitis data, which as per the press release below, sounds like is quite promising.
https://globenewswire.com/news-rele...-Colitis-Symptoms-in-Preclinical-Program.html
Preclinical yes but IBD is another huge market and just another piece of Immuron's value.
- Forums
- ASX - By Stock
- IMC
- Big Pharma Partnership
Big Pharma Partnership, page-65
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
-0.003(3.85%) |
Mkt cap ! $17.18M |
Open | High | Low | Value | Volume |
7.7¢ | 7.7¢ | 7.5¢ | $5.59K | 73.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16083 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.6¢ | 6857 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 16083 | 0.075 |
1 | 20000 | 0.074 |
3 | 27698 | 0.073 |
1 | 125000 | 0.072 |
2 | 130000 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.076 | 6857 | 1 |
0.085 | 77613 | 2 |
0.086 | 147746 | 1 |
0.088 | 96511 | 2 |
0.099 | 1300 | 1 |
Last trade - 15.31pm 05/11/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |